QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 251 filers reported holding QIAGEN NV in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $301,000 | -0.7% | 6,212 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $303,000 | -7.6% | 6,212 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $328,000 | +11.2% | 6,212 | +10.2% | 0.00% | 0.0% |
| Q3 2020 | $295,000 | +21.9% | 5,636 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $242,000 | -26.4% | 5,636 | -28.6% | 0.00% | -40.0% |
| Q1 2020 | $329,000 | +22.8% | 7,896 | 0.0% | 0.01% | +66.7% |
| Q4 2019 | $268,000 | -33.2% | 7,896 | -34.9% | 0.00% | -25.0% |
| Q3 2019 | $401,000 | -18.7% | 12,136 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $493,000 | -0.2% | 12,136 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $494,000 | +17.9% | 12,136 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $419,000 | -8.9% | 12,136 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $460,000 | -14.2% | 12,136 | -18.2% | 0.00% | -20.0% |
| Q2 2018 | $536,000 | +22.1% | 14,836 | +9.1% | 0.01% | 0.0% |
| Q1 2018 | $439,000 | +4.5% | 13,594 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $420,000 | -1.9% | 13,594 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $428,000 | -6.1% | 13,594 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $456,000 | +17.8% | 13,594 | +1.7% | 0.00% | +33.3% |
| Q1 2017 | $387,000 | – | 13,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |